Charles River Laboratories International Inc. (CRL) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Charles River Laboratories International Inc., updated every trading day.
Health Care · Biotechnology: Commercial Physical & Biological Resarch
Price
$373.98
+4.22% today
Market cap
$17.1B
Overall quality
37/100
Kronos AI 30-day
−36.3%
0 of 8 simulated paths end higher
Charles River Laboratories International Inc. (CRL) is a Health Care company in Biotechnology: Commercial Physical & Biological Resarch, worth $17.1B. It trades at $373.98, up 4.22% today. Its overall quality score is 37 out of 100, ranked against the whole US market. 14 analysts' average target of $329.85 implies −11.8% from today's price. Kronos AI's 30-day forecast is −36.3% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $329.85 |
| Low – high | $295.00 – $357.00 |
| Analysts | 14 |
| Upside to average | −11.8% |
Kronos AI 30-day forecast
| Expected close | $228.57 (−36.3%) |
| Likely range | −45.6% … −32.3% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
| Profitability | 47 |
| Solvency | 41 |
| Growth | 22 |
| Overall | 37 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Commercial Physical & Biological Resarch
For information only, not investment advice. Prices updated: 2026-10-29.